ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1697838
CHEMBL1697838
Compound Name GLYMIDINE
ChEMBL Synonyms SH-717 | Glymidine | Glymidine Sodium
Max Phase 0
Trade Names
Molecular Formula C13H15N3O4S

Additional synonyms for CHEMBL1697838 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1
Standard InChI InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21( ...
Download InChI
Standard InChI Key QFWPJPIVLCBXFJ-UHFFFAOYSA-N

Molecule Features

CHEMBL1697838 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:Y First In Class:N Chirality:Achiral Molecule Prodrug:N Oral:Unclassified Parenteral:Unclassified Topical:Unclassified Black Box:Unclassified Availability Type:Unclassified

Clinical Data

Number of clinical trials registered at clinicaltrials.gov
Number of reviews at The Cochrane Collaboration
Number of entries at British National Formulary

Structural Alerts

There are 2 structural alerts for CHEMBL1697838. To view alerts please click here.

Alternate Forms of Compound in ChEMBL


CHEMBL1697838

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
309.3 309.0783 0.91 7 98.79 ACID


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
6 1 0 7 1 0


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
5.66 - -.07 -1.62 2 21 0.76

Compound Cross References

ATC A - ALIMENTARY TRACT AND METABOLISM
A10 - DRUGS USED IN DIABETES
A10B - BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BC - Sulfonamides (heterocyclic)
A10BC01 - glymidine

ChemSpider ChemSpider:QFWPJPIVLCBXFJ-UHFFFAOYSA-N
Wikipedia Glymidine_sodium

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL1697838



ACToR 339-44-6
DrugBank DB01382
FDA SRS 4C5I4BQZ8F
Human Metabolome Database HMDB15461
IBM Patent System B8AB51E4AD2AB984B853DD1E5C967623
IBM Patents WO2009103035A2 US4337267 US20080221175 US7687528 US20050119274 WO2009015286A2 EP2124991A1 US7632852 US20070154560 WO2007105113A2 US20100152156 EP0665010B1 WO1999015210A2 US20020107420 EP1727520A2 WO2007016766A1 WO2008156601A1 US20080312277 US20080124706 US20060122174 WO2008068423A2 US20070072907 EP2138175A2 US20040106649 WO2002039983A2 US20080015229 EP0253901A1 US20070269379 EP1853264A1 US6677363 EP0495963A1 US20100168039 US20090297600 EP1703908A1 WO2010136493A1 EP1305628A2 US6121295 US20100280457 EP1402900A1 US6232330 WO2004000295A1 US7648989 WO2002066509A2 US20100009378 EP1927594A1 US20040052855 WO2005119252A2 US20070191377 WO2010034118A1 US20060194879 US6113943 EP1973541B1 US20080293678 EP0580860A1 EP1971340A2 EP1907357A1 EP2242489A1 EP1254659B1 US20050232954 WO2006130174A2 WO2005018561A2 EP0902777A1 US20070021502 WO2006137793A1 US20040180949 US20040266830 WO2010078300A1 WO2005117591A2 US7659287 WO2007075542A2 EP1692107A2 EP0761213A3 US6902902 WO2006087481A1 US5656286 US20090215838 US20080070962 WO2007033292A2 WO2006125818A2 US20090238860 US20080161296 EP1599468B1 EP0452837B1 US7829298 US7534808 EP0732122B1 WO2005070006A2 WO2006041855A2 EP1597250B1 US20070032533 US7691861 US20090004229 US4990340 EP2075249A2 US20040241219 WO2006078995A1 US20030212114 US7049082 US20090271124 US20100048562
Nikkaji J9.361K
PubChem 9565
PubChem: Thomson Pharma 16827979
SureChEMBL SCHEMBL34389

UniChem REST Service Call: https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/QFWPJPIVLCBXFJ-UHFFFAOYSA-N spacer
spacer